Aktive Positionen von Andrew Muratore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 17.11.2021 | - |
| Corporate Officer/Principal | 17.11.2021 | - |
Karriereverlauf von Andrew Muratore
Statistik
International
| Kanada | 2 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Börse
- Insiders
- Andrew Muratore
- Erfahrung
